All In MedTech

FDA Clearance Tracker · P080004-S028

IPure Preloaded IOL System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 23, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 23, 2020

Approved

Time to decision

143 days

Received Dec 2, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080004-S028
Device name
IPure Preloaded IOL System
Applicant location
Chino Hills, CA
Received
Dec 2, 2019
Decided
Apr 23, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P080004

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

Approval for packaging changes for the iSert® Preloaded System Platform Models 230 and 231. The device, as modified, will be marketed under the trade name IPure Preloaded IOL System Model B3PC and B3PY.

Source documents

Other decisions for Hoya Surgical Optics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.